SII Applies To DCGI To Manufacture Covid Vaccine Sputnik V

NEW DELHI : The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture Covid-19 vaccine Sputnik V in the country, sources said on Thursday.

The Pune-based firm has also sought approval for test analysis and examination. Russia’s Sputnik V vaccine is currently being manufactured in India by Dr Reddy’s Laboratories.

“The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the Covid-19 vaccine, Sputnik V, in India,” a source said.

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.

The vaccine was given emergency use authorisation (EUA) by the DCGI in April. A consignment of 30 lakh doses of Sputnik V landed in Hyderabad on Tuesday.

  • Related Posts

    Six Women Develop Serious Complications After C-Section

    Jaipur/Kota — In a serious medical incident that has raised concerns over patient safety at government facilities, six women who underwent caesarean section deliveries at Kota’s New Medical College Hospital developed…

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Jaipur:  Continuing its statewide anti-adulteration and food safety enforcement drive, the Food Safety Department Rajasthan conducted a major inspection and sampling operation at a pharma biological manufacturing unit located in…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Six Women Develop Serious Complications After C-Section

    Six Women Develop Serious Complications After C-Section

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Indian Pharma Majors Plan to Invest in US

    Indian Pharma Majors Plan to Invest in US

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

    Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental